Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

Published:2016-07 Issue:7 Volume:18 Page:413-424
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Torimura Takuji,Iwamoto Hideki,Nakamura Toru,Abe Mitsuhiko,Ikezono Yu,Wada Fumitaka,Sakaue Takahiko,Masuda Hiroshi,Hashimoto Osamu,Koga Hironori,Ueno Takato,Yano Hirohisa

Publisher

Elsevier BV

Subject

Cancer Research

Reference47 articles.

1. Tumor angiogenesis: molecular pathways and therapeutic targets;Weis;Nat Med,2011

2. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy;Jain;Science,2005

3. A role for VEGF as a negative regulator of pericyte function and vessel maturation;Greenberg;Nature,2008

4. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis;Hicklin;J Clin Oncol,2005

5. VEGF-targeted therapy: mechanisms of anti-tumour activity;Ellis;Nat Rev Cancer,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models;Advanced Healthcare Materials;2024-03-22

2. New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow;International Journal of Molecular Sciences;2024-01-25

3. Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD;Molecular Therapy - Methods & Clinical Development;2023-09

4. Network analysis and the impact of Aflibercept on specific mediators of angiogenesis in HUVEC cells;Journal of Cellular and Molecular Medicine;2021-07-11

5. The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice;Acta Pharmacologica Sinica;2020-12-10